Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 129 entries
Sorted by: Best Match Show Resources per page
Clinical Characteristics and Laboratory Identification of .

International journal of microbiology

Narayanasamy S, King K, Dennison A, Spelman DW, Aung AK.
PMID: 29056969
Int J Microbiol. 2017;2017:5684614. doi: 10.1155/2017/5684614. Epub 2017 Sep 13.

Aerococci uncommonly cause urinary tract (UTI) and bloodstream infections (BSI). The clinical characteristics and laboratory identification rates of

Cite
Narayanasamy S, King K, Dennison A, et al. Clinical Characteristics and Laboratory Identification of . Int J Microbiol. 2017;2017:5684614doi: 10.1155/2017/5684614.
Narayanasamy, S., King, K., Dennison, A., Spelman, D. W., & Aung, A. K. (2017). Clinical Characteristics and Laboratory Identification of . International journal of microbiology, 20175684614. https://doi.org/10.1155/2017/5684614
Narayanasamy, Shanti, et al. "Clinical Characteristics and Laboratory Identification of ." International journal of microbiology vol. 2017 (2017): 5684614. doi: https://doi.org/10.1155/2017/5684614
Narayanasamy S, King K, Dennison A, Spelman DW, Aung AK. Clinical Characteristics and Laboratory Identification of . Int J Microbiol. 2017;2017:5684614. doi: 10.1155/2017/5684614. Epub 2017 Sep 13. PMID: 29056969; PMCID: PMC5615948.
Copy Download .nbib Format: NLM
Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210.

Genome announcements

Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY.
PMID: 26067951
Genome Announc. 2015 Jun 11;3(3). doi: 10.1128/genomeA.00568-15.

To assess the genetic factors contributing to daptomycin resistance in Staphylococcus aureus, the draft genome of a clinically derived daptomycin-nonsusceptible isolate APS211 was generated and compared to the draft sequence of its susceptible progenitor strain APS210. Four genetic differences...

Cite
Cameron DR, Jiang JH, Abbott IJ, et al. Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome Announc. 2015;3(3)doi: 10.1128/genomeA.00568-15.
Cameron, D. R., Jiang, J. H., Abbott, I. J., Spelman, D. W., & Peleg, A. Y. (2015). Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome announcements, 3(3), . https://doi.org/10.1128/genomeA.00568-15
Cameron, David R, et al. "Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210." Genome announcements vol. 3,3 (2015). doi: https://doi.org/10.1128/genomeA.00568-15
Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY. Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome Announc. 2015 Jun 11;3(3). doi: 10.1128/genomeA.00568-15. PMID: 26067951; PMCID: PMC4463516.
Copy Download .nbib Format: NLM
The Physical Health of Patients with Advanced Pancreatic Cancer and the Psychological Health of their Family Caregivers When Newly Enrolled in Hospice.

Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association

Sherman DW, McMillan SC.
PMID: 26617469
J Hosp Palliat Nurs. 2015 May-Jun;17(3):235-241. doi: 10.1097/NJH.0000000000000154.

No abstract available.

Cite
Sherman DW, McMillan SC. The Physical Health of Patients with Advanced Pancreatic Cancer and the Psychological Health of their Family Caregivers When Newly Enrolled in Hospice. J Hosp Palliat Nurs. 2015;17(3):235-241doi: 10.1097/NJH.0000000000000154.
Sherman, D. W., & McMillan, S. C. (2015). The Physical Health of Patients with Advanced Pancreatic Cancer and the Psychological Health of their Family Caregivers When Newly Enrolled in Hospice. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association, 17(3), 235-241. https://doi.org/10.1097/NJH.0000000000000154
Sherman, Deborah Witt, and McMillan, Susan C. "The Physical Health of Patients with Advanced Pancreatic Cancer and the Psychological Health of their Family Caregivers When Newly Enrolled in Hospice." Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association vol. 17,3 (2015): 235-241. doi: https://doi.org/10.1097/NJH.0000000000000154
Sherman DW, McMillan SC. The Physical Health of Patients with Advanced Pancreatic Cancer and the Psychological Health of their Family Caregivers When Newly Enrolled in Hospice. J Hosp Palliat Nurs. 2015 May-Jun;17(3):235-241. doi: 10.1097/NJH.0000000000000154. PMID: 26617469; PMCID: PMC4657749.
Copy Download .nbib Format: NLM
A case of gonococcal necrotising fasciitis.

Sexual health

Kanhutu KN, Spelman DD, Weymouth MD.
PMID: 25054272
Sex Health. 2014 Jul;11(3):280-2. doi: 10.1071/SH14027.

This case report details the progress of a patient with severe disseminated gonococcal infection with associated necrotising fasciitis. His admission was punctuated by multiple surgical debridements and a prolonged intensive care stay due to multiple organ failure. An extended...

Cite
Kanhutu KN, Spelman DD, Weymouth MD. A case of gonococcal necrotising fasciitis. Sex Health. 2014;11(3):280-2doi: 10.1071/SH14027.
Kanhutu, K. N., Spelman, D. D., & Weymouth, M. D. (2014). A case of gonococcal necrotising fasciitis. Sexual health, 11(3), 280-2. https://doi.org/10.1071/SH14027
Kanhutu, Kudzai Nzenza, et al. "A case of gonococcal necrotising fasciitis." Sexual health vol. 11,3 (2014): 280-2. doi: https://doi.org/10.1071/SH14027
Kanhutu KN, Spelman DD, Weymouth MD. A case of gonococcal necrotising fasciitis. Sex Health. 2014 Jul;11(3):280-2. doi: 10.1071/SH14027. PMID: 25054272.
Copy Download .nbib Format: NLM
Host-Pathogen Interactions : XX. BIOLOGICAL VARIATION IN THE PROTECTION OF SOYBEANS FROM INFECTION BY PHYTOPHTHORA MEGASPERMA F. SP. GLYCINEA.

Plant physiology

Desjardins AE, Ross LM, Spellman MW, Darvill AG, Albersheim P.
PMID: 16662342
Plant Physiol. 1982 May;69(5):1046-50. doi: 10.1104/pp.69.5.1046.

Phytophthora megasperma f.sp. glycinea, which causes soybean (Glycine max) root and stem rot, exists as several races which differ in their ability to infect a range of soybean cultivars. A glycoprotein-rich fraction (Fraction I) isolated from fungal culture fluid...

Cite
Desjardins AE, Ross LM, Spellman MW, et al. Host-Pathogen Interactions : XX. BIOLOGICAL VARIATION IN THE PROTECTION OF SOYBEANS FROM INFECTION BY PHYTOPHTHORA MEGASPERMA F. SP. GLYCINEA. Plant Physiol. 1982;69(5):1046-50doi: 10.1104/pp.69.5.1046.
Desjardins, A. E., Ross, L. M., Spellman, M. W., Darvill, A. G., & Albersheim, P. (1982). Host-Pathogen Interactions : XX. BIOLOGICAL VARIATION IN THE PROTECTION OF SOYBEANS FROM INFECTION BY PHYTOPHTHORA MEGASPERMA F. SP. GLYCINEA. Plant physiology, 69(5), 1046-50. https://doi.org/10.1104/pp.69.5.1046
Desjardins, A E, et al. "Host-Pathogen Interactions : XX. BIOLOGICAL VARIATION IN THE PROTECTION OF SOYBEANS FROM INFECTION BY PHYTOPHTHORA MEGASPERMA F. SP. GLYCINEA." Plant physiology vol. 69,5 (1982): 1046-50. doi: https://doi.org/10.1104/pp.69.5.1046
Desjardins AE, Ross LM, Spellman MW, Darvill AG, Albersheim P. Host-Pathogen Interactions : XX. BIOLOGICAL VARIATION IN THE PROTECTION OF SOYBEANS FROM INFECTION BY PHYTOPHTHORA MEGASPERMA F. SP. GLYCINEA. Plant Physiol. 1982 May;69(5):1046-50. doi: 10.1104/pp.69.5.1046. PMID: 16662342; PMCID: PMC426356.
Copy Download .nbib Format: NLM
Establishing a corky ringspot disease plot for research purposes.

Journal of nematology

Mojtahedi H, Boydston RA, Crosslin JM, Brown CR, Riga E, Anderson TL, Spellman D, Quick RA.
PMID: 19259504
J Nematol. 2007 Dec;39(4):313-6.

A method to establish two experimental corky ringspot disease (CRS) plots that had no prior CRS history is described. CRS is a serious disease of potato in the Pacific Northwest caused by tobacco rattle virus (TRV) and transmitted primarily...

Cite
Mojtahedi H, Boydston RA, Crosslin JM, et al. Establishing a corky ringspot disease plot for research purposes. J Nematol. 2007;39(4):313-6
Mojtahedi, H., Boydston, R. A., Crosslin, J. M., Brown, C. R., Riga, E., Anderson, T. L., Spellman, D., & Quick, R. A. (2007). Establishing a corky ringspot disease plot for research purposes. Journal of nematology, 39(4), 313-6.
Mojtahedi, H, et al. "Establishing a corky ringspot disease plot for research purposes." Journal of nematology vol. 39,4 (2007): 313-6.
Mojtahedi H, Boydston RA, Crosslin JM, Brown CR, Riga E, Anderson TL, Spellman D, Quick RA. Establishing a corky ringspot disease plot for research purposes. J Nematol. 2007 Dec;39(4):313-6. PMID: 19259504; PMCID: PMC2586511.
Copy Download .nbib Format: NLM
Management of progressive type 2 diabetes: role of insulin therapy.

Osteopathic medicine and primary care

Chemitiganti RR, Spellman CW.
PMID: 19573240
Osteopath Med Prim Care. 2009 Jul 02;3:5. doi: 10.1186/1750-4732-3-5.

Insulin is an effective treatment for achieving tight glycemic control and improving clinical outcomes in patients with diabetes. While insulin therapy is required from the onset of diagnosis in type 1 disease, its role in type 2 diabetes requires...

Cite
Chemitiganti RR, Spellman CW. Management of progressive type 2 diabetes: role of insulin therapy. Osteopath Med Prim Care. 2009;3:5doi: 10.1186/1750-4732-3-5.
Chemitiganti, R. R., & Spellman, C. W. (2009). Management of progressive type 2 diabetes: role of insulin therapy. Osteopathic medicine and primary care, 35. https://doi.org/10.1186/1750-4732-3-5
Chemitiganti, Ramachandra Rahul V, and Spellman, Craig W. "Management of progressive type 2 diabetes: role of insulin therapy." Osteopathic medicine and primary care vol. 3 (2009): 5. doi: https://doi.org/10.1186/1750-4732-3-5
Chemitiganti RR, Spellman CW. Management of progressive type 2 diabetes: role of insulin therapy. Osteopath Med Prim Care. 2009 Jul 02;3:5. doi: 10.1186/1750-4732-3-5. PMID: 19573240; PMCID: PMC2716354.
Copy Download .nbib Format: NLM
Eigenstructure approach to directions-of-arrival estimation in IR detector arrays.

Applied optics

Spielman D, Paulraj A, Kailath T.
PMID: 20454104
Appl Opt. 1987 Jan 15;26(2):199-202. doi: 10.1364/AO.26.000199.

No abstract available.

Cite
Spielman D, Paulraj A, Kailath T. Eigenstructure approach to directions-of-arrival estimation in IR detector arrays. Appl Opt. 1987;26(2):199-202doi: 10.1364/AO.26.000199.
Spielman, D., Paulraj, A., & Kailath, T. (1987). Eigenstructure approach to directions-of-arrival estimation in IR detector arrays. Applied optics, 26(2), 199-202. https://doi.org/10.1364/AO.26.000199
Spielman, D, et al. "Eigenstructure approach to directions-of-arrival estimation in IR detector arrays." Applied optics vol. 26,2 (1987): 199-202. doi: https://doi.org/10.1364/AO.26.000199
Spielman D, Paulraj A, Kailath T. Eigenstructure approach to directions-of-arrival estimation in IR detector arrays. Appl Opt. 1987 Jan 15;26(2):199-202. doi: 10.1364/AO.26.000199. PMID: 20454104.
Copy Download .nbib Format: NLM
Ventricular assist device infections.

Current infectious disease reports

Spelman D, Esmore D.
PMID: 22562182
Curr Infect Dis Rep. 2012 Aug;14(4):359-66. doi: 10.1007/s11908-012-0261-9.

Ventricular Assist Devices(VAD) are the commonest form of cardiac mechanical support, used as bridge to transplantation but also as destination therapy in non-transplant-eligible patients in whom transplantation is considered unsuitable based on age criteria. Infections are common and can...

Cite
Spelman D, Esmore D. Ventricular assist device infections. Curr Infect Dis Rep. 2012;14(4):359-66doi: 10.1007/s11908-012-0261-9.
Spelman, D., & Esmore, D. (2012). Ventricular assist device infections. Current infectious disease reports, 14(4), 359-66. https://doi.org/10.1007/s11908-012-0261-9
Spelman, Denis, and Esmore, Donald. "Ventricular assist device infections." Current infectious disease reports vol. 14,4 (2012): 359-66. doi: https://doi.org/10.1007/s11908-012-0261-9
Spelman D, Esmore D. Ventricular assist device infections. Curr Infect Dis Rep. 2012 Aug;14(4):359-66. doi: 10.1007/s11908-012-0261-9. PMID: 22562182.
Copy Download .nbib Format: NLM
The "FDA approval defense": penetrating the protective shield.

The International journal of risk & safety in medicine

Sigelman DW.
PMID: 23511255
Int J Risk Saf Med. 1994;4(3):179-90. doi: 10.3233/JRS-1994-4301.

No abstract available.

Cite
Sigelman DW. The "FDA approval defense": penetrating the protective shield. Int J Risk Saf Med. 1994;4(3):179-90doi: 10.3233/JRS-1994-4301.
Sigelman, D. W. (1994). The "FDA approval defense": penetrating the protective shield. The International journal of risk & safety in medicine, 4(3), 179-90. https://doi.org/10.3233/JRS-1994-4301
Sigelman, D W. "The "FDA approval defense": penetrating the protective shield." The International journal of risk & safety in medicine vol. 4,3 (1994): 179-90. doi: https://doi.org/10.3233/JRS-1994-4301
Sigelman DW. The "FDA approval defense": penetrating the protective shield. Int J Risk Saf Med. 1994;4(3):179-90. doi: 10.3233/JRS-1994-4301. PMID: 23511255.
Copy Download .nbib Format: NLM
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study.

Journal of neurodevelopmental disorders

Bruno JL, Shelly EW, Quintin EM, Rostami M, Patnaik S, Spielman D, Mayer D, Gu M, Lightbody AA, Reiss AL.
PMID: 23981510
J Neurodev Disord. 2013 Aug 28;5(1):20. doi: 10.1186/1866-1955-5-20.

BACKGROUND: The profile of cognitive and behavioral variation observed in individuals with fragile X syndrome (FXS), the most common known cause of inherited intellectual impairment, suggests aberrant functioning of specific brain systems. Research investigating animal models of FXS, characterized...

Cite
Bruno JL, Shelly EW, Quintin EM, et al. Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study. J Neurodev Disord. 2013;5(1):20doi: 10.1186/1866-1955-5-20.
Bruno, J. L., Shelly, E. W., Quintin, E. M., Rostami, M., Patnaik, S., Spielman, D., Mayer, D., Gu, M., Lightbody, A. A., & Reiss, A. L. (2013). Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study. Journal of neurodevelopmental disorders, 5(1), 20. https://doi.org/10.1186/1866-1955-5-20
Bruno, Jennifer Lynn, et al. "Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study." Journal of neurodevelopmental disorders vol. 5,1 (2013): 20. doi: https://doi.org/10.1186/1866-1955-5-20
Bruno JL, Shelly EW, Quintin EM, Rostami M, Patnaik S, Spielman D, Mayer D, Gu M, Lightbody AA, Reiss AL. Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study. J Neurodev Disord. 2013 Aug 28;5(1):20. doi: 10.1186/1866-1955-5-20. PMID: 23981510; PMCID: PMC3766683.
Copy Download .nbib Format: NLM
Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration.

JAMA internal medicine

Chahal HS, Szeto D, Chaudhry AH, Sigelman DW, Kim S, Lurie PG.
PMID: 31157824
JAMA Intern Med. 2019 Aug 01;179(8):1144-1146. doi: 10.1001/jamainternmed.2019.1213.

No abstract available.

Cite
Chahal HS, Szeto D, Chaudhry AH, et al. Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration. JAMA Intern Med. 2019;179(8):1144-1146doi: 10.1001/jamainternmed.2019.1213.
Chahal, H. S., Szeto, D., Chaudhry, A. H., Sigelman, D. W., Kim, S., & Lurie, P. G. (2019). Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration. JAMA internal medicine, 179(8), 1144-1146. https://doi.org/10.1001/jamainternmed.2019.1213
Chahal, Harinder Singh, et al. "Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration." JAMA internal medicine vol. 179,8 (2019): 1144-1146. doi: https://doi.org/10.1001/jamainternmed.2019.1213
Chahal HS, Szeto D, Chaudhry AH, Sigelman DW, Kim S, Lurie PG. Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration. JAMA Intern Med. 2019 Aug 01;179(8):1144-1146. doi: 10.1001/jamainternmed.2019.1213. PMID: 31157824; PMCID: PMC6547098.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 129 entries